Breast cancer incidence is increasing and predicted to be over 3 million per year by 2040. It is in this context that the Lancet Breast cancer commission, a diverse multidisciplinary international commission, was convened in July 2021. The Lancet Breast Cancer Commission report showed glaring inequities, with many groups with breast cancer being systematically left behind and forgotten.
This webinar will discuss the inclusive, evidence-based roadmap laid out by the Lance Breast Cancer Commission to address urgent breast cancer challenges. They can and should be tackled.
Dr Cui's areas of interest are cancer and pregnancy, understanding and preventing the unwanted effects of cancer treatments on ovarian function and fertility, and cancer prevention. Her research focuses on oncofertility and cancer prevention. She is the first author of the ASCO research statement regarding assessing ovarian toxicity in cancer clinical trials. She is a member of the prevention working group of the Lancet Breast Cancer Commission and is the Breast Cancer Trials Australia deputy chair for the Decrescendo trial.
